Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Shares Repurchased (2017 - 2025)

Usana Health Sciences (USNA) has disclosed Shares Repurchased for 14 consecutive years, with $15.2 million as the latest value for Q2 2025.

  • Quarterly Shares Repurchased changed N/A to $15.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $27.5 million through Jan 2026, up 191.26% year-over-year, with the annual reading at $27.5 million for FY2026, 191.26% up from the prior year.
  • Shares Repurchased for Q2 2025 was $15.2 million at Usana Health Sciences, up from $12.3 million in the prior quarter.
  • The five-year high for Shares Repurchased was $120.8 million in Q1 2022, with the low at $9.4 million in Q1 2024.
  • Average Shares Repurchased over 5 years is $37.5 million, with a median of $15.2 million recorded in 2025.
  • The sharpest move saw Shares Repurchased plummeted 62.46% in 2022, then soared 30.24% in 2025.
  • Over 5 years, Shares Repurchased stood at $67.6 million in 2021, then tumbled by 62.46% to $25.4 million in 2022, then plummeted by 54.3% to $11.6 million in 2023, then fell by 18.58% to $9.4 million in 2024, then soared by 61.02% to $15.2 million in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $15.2 million, $12.3 million, and $9.4 million for Q2 2025, Q1 2025, and Q1 2024 respectively.